MARK S. ORDAN - 15 Dec 2025 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role
Chief Executive Officer, Director
Signature
/s/ Mary Ann E. Moore, Attorney-in-Fact
Issuer symbol
MD
Transactions as of
15 Dec 2025
Net transactions value
-$515,430
Form type
4
Filing time
17 Dec 2025, 17:00:02 UTC
Previous filing
03 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ORDAN MARK S Chief Executive Officer, Director 1301 CONCORD TERRACE, SUNRISE /s/ Mary Ann E. Moore, Attorney-in-Fact 17 Dec 2025 0001208541

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Sale $515,430 -23,000 -7.1% $22.41 302,805 15 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $22.00 to $22.62 for a weighted average sales price of $22.41. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.

Remarks:

See Exhibit 24.1 - Power of Attorney